The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients

Transplant Immunology

Volumn 29, Issue 1-4, 2013, Pages 17-21

  Guidicelli, Gwendaline ^a,e   Anies, Guerric ^a,b   Bachelet, Thomas ^b   Dubois, Valérie ^c   Moreau, Jean François ^a,b   Merville, Pierre ^a,b,d   Couzi, Lionel ^a,d   Taupin, Jean Luc ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b CNRS Bordeaux Segalen University   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e Laboratoire d'Immunologie et Immunogénétique HÔpital Pellegrin   (France)

Author keywords

Crossmatch; HLA antibody; Prozone phenomenon; Single antigen flow bead assay

Indexed keywords

HLA ANTIBODY;

ALLOIMMUNITY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; COHORT ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY CROSSMATCH; COMPLEMENT FIXATION; COMPLEMENT INTERFERENCE; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOTOXICITY ASSAY; FEMALE; FLOW CYTOMETRY; FLOW CYTOMETRY CROSSMATCH; GRAFT RECIPIENT; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROZONE; RISK ASSESSMENT; SINGLE ANTIGEN FLOW BEAD ASSAY;

CDCXM; COMPLEMENT-DEPENDENT CYTOTOXICITY CROSSMATCH; CROSSMATCH; DITHIOTHREITOL; DONOR-SPECIFIC ANTIBODIES; DSA; DTT; EDTA; ETHYLENE DIAMINE TETRACETIC ACID; FCXM; FLOW CYTOMETRY CROSSMATCH; HLA ANTIBODY; MCS; MEAN FLUORESCENCE CHANNEL SHIFT; MEAN FLUORESCENCE INTENSITY; MFI; PROZONE PHENOMENON; SAFB; SINGLE ANTIGEN FLOW BEAD; SINGLE ANTIGEN FLOW BEAD ASSAY; VIRTUAL CROSSMATCH; VXM; XM;

ALLOGRAFTS; COMPLEMENT SYSTEM PROTEINS; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES;

EID: 84897106988     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.09.005     Document Type: Article

References (14)

1. Gebel H.M., Bray R.A. The evolution and clinical impact of human leukocyte antigen technology. Curr Opin Nephrol Hypertens 2010, 19:598-602.
2. Bray R.A., Nolen J.D., Larsen C., Pearson T., Newell K.A., Kokko K., et al. Transplanting the highly sensitized patient: the emory algorithm. Am J Transplant 2006, 6:2307-2315.
3. Cecka J.M., Kucheryavaya A.Y., Reinsmoen N.L., Leffell M.S. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant 2010, 11:719-724.
4. Schnaidt M., Weinstock C., Jurisic M., Schmid-Horch B., Ender A., Wernet D. HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation 2011, 92:510-515.
5. Kosmoliaptsis V., O'Rourke C., Bradley J.A., Taylor C.J. Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera. Hum Immunol 2010, 71:45-49.
6. Kosmoliaptsis V., Bradley J.A., Peacock S., Chaudhry A.N., Taylor C.J. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Transplantation 2009, 87:813-820.
7. Zachary A.A., Lucas D.P., Detrick B., Leffell M.S. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 2009, 70:496-501.
8. Lefaucheur C., Antoine C., Suberbielle C., Glotz D. Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques. Am J Transplant 2011, 11:1592-1598.
9. Couzi L., Araujo C., Guidicelli G., Bachelet T., Moreau K., Morel D., et al. Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay. Transplantation 2011, 91:527-535.
10. Taylor C.J., Kosmoliaptsis V., Summers D.M., Bradley J.A. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation. Hum Immunol 2009, 70:563-568.
11. Fuller T.C., Fuller A.A., Golden M., Rodey G.E. HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure. Hum Immunol 1997, 56:94-105.
12. van Meerten T., van Rijn R.S., Hol S., Hagenbeek A., Ebeling S.B. Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity. Clin Cancer Res 2006, 12:4027-4035.
13. Weinstock C., Schnaidt M. The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera. Int J Immunogenet 2013, 40:171-177.
14. Lefaucheur C., Loupy A., Hill G.S., Andrade J., Nochy D., Antoine C., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21:1398-1406.